Anderson W K, Chang C P, Corey P F, Halat M J, Jones A N, McPherson H L, New J S, Rich A C
Cancer Treat Rep. 1982 Jan;66(1):91-7.
The activity of three pyrroles and four pyrrolizines is compared in several different experimental leukemias and solid tumors in mice. Two compounds were particularly noteworthy, the bis(N-cyclohexylcarbamate) and the bis[N-(2-propyl)] derivatives of 2,3-dihydro-5-(3,4-dichlorophenyl)-6,7-bis(hydroxymethyl)-1H-pyrrolizine. These two compounds showed a very high level of activity against B16 melanocarcinoma, CD8F1 mammary tumor, colon tumor 26, and colon tumor 38, and a significant number of "cures" were recorded. The isopropyl compound was more potent than the cyclohexyl compound, but both showed a similar profile of activity.
在小鼠的几种不同实验性白血病和实体瘤中比较了三种吡咯和四种吡咯嗪的活性。有两种化合物特别值得注意,即2,3-二氢-5-(3,4-二氯苯基)-6,7-双(羟甲基)-1H-吡咯嗪的双(N-环己基氨基甲酸酯)和双[N-(2-丙基)]衍生物。这两种化合物对B16黑色素瘤、CD8F1乳腺肿瘤、结肠肿瘤26和结肠肿瘤38显示出非常高的活性水平,并且记录到了大量的“治愈”病例。异丙基化合物比环己基化合物更有效,但两者显示出相似的活性谱。